Calviri Publishes Results Demonstrating Sensitive Detection of Stage 1 Tumors in Dogs
PRIVATEPHOENIX, June 17, 2025 /PRNewswire/ -- Calviri, Inc, a company focused on ending cancer in dogs and people, announces the publication of High-sensitivity multicancer detection of stage 1 cancer in dogs in the American Journal of Veterinary Research of a novel diagnostic for the sensitive...
Object First Named Immutable Storage Company of the Year and Editor’s Choice at Storage Awards
PRIVATEBEVERLY, Mass.--(BUSINESS WIRE)--Object First, the creator of Ootbi (Out-of-the-Box-Immutability), the ransomware-proof backup storage appliance purpose-built for Veeam®, was recognized for its innovation and industry leadership with two major honors at the 22nd annual Storage Awards in London on June 5, 2025: Immutable Storage Company of the Year and Editor’s Choice – Company. This is the second consecutive year Object First has been named the Immutable Storage Company of the Year, a category
Object First Named Immutable Storage Company of the Year and Editor’s Choice at Storage Awards
PRIVATEBEVERLY, Mass.--(BUSINESS WIRE)--Object First, the creator of Ootbi (Out-of-the-Box-Immutability), the ransomware-proof backup storage appliance purpose-built for Veeam®, was recognized for its innovation and industry leadership with two major honors at the 22nd annual Storage Awards in London on June 5, 2025: Immutable Storage Company of the Year and Editor’s Choice – Company. This is the second consecutive year Object First has been named the Immutable Storage Company of the Year, a category
Somnics Health Launches iNAP Essentials: Making Innovative OSA Therapy Accessible for $58/Month
PRIVATEREDWOOD CITY, Calif.--(BUSINESS WIRE)--Somnics Health, a pioneer in next-generation sleep apnea solutions, announces the launch of iNAP Essentials, a breakthrough program giving patients access to iNAP Sleep Therapy for just $58/month over 24 months. This new initiative removes one of the biggest barriers to treatment—cost—and expands access to comfortable, mask-free therapy for patients with Obstructive Sleep Apnea (OSA). More than 50 million Americans suffer from OSA, yet 80% remain untreated